178 related articles for article (PubMed ID: 29116892)
1. Lessons from the Meningitis Vaccine Project.
LaForce FM; Djingarey M; Viviani S; Preziosi MP
Viral Immunol; 2018 Mar; 31(2):109-113. PubMed ID: 29116892
[TBL] [Abstract][Full Text] [Related]
2. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.
Aguado MT; Jodar L; Granoff D; Rabinovich R; Ceccarini C; Perkin GW
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S391-5. PubMed ID: 26553665
[TBL] [Abstract][Full Text] [Related]
3. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
LaForce FM; Djingarey M; Viviani S; Preziosi MP
Hum Vaccin Immunother; 2018 May; 14(5):1098-1102. PubMed ID: 28968148
[TBL] [Abstract][Full Text] [Related]
4. Technical Development of a New Meningococcal Conjugate Vaccine.
Frasch CE; Kapre SV; Lee CH; Préaud JM
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S404-9. PubMed ID: 26553667
[TBL] [Abstract][Full Text] [Related]
5. Documenting the Results of a Successful Partnership: A New Meningococcal Vaccine for Africa.
Okwo-Bele JM; LaForce FM; Borrow R; Preziosi MP
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S389-90. PubMed ID: 26553664
[No Abstract] [Full Text] [Related]
6. A Vaccine Meets Its Promise: Success in Controlling Epidemic Meningitis in Sub-Saharan Africa.
Sambo L; Chan M; Davis S; Lake A; Berkley S; Poonawalla C; Elias CJ
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S387-8. PubMed ID: 26553663
[No Abstract] [Full Text] [Related]
7. Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVac
Kulkarni PS; Jadhav SS; LaForce FM
Hum Vaccin Immunother; 2018 May; 14(5):1103-1106. PubMed ID: 29048988
[TBL] [Abstract][Full Text] [Related]
8. Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018.
Bwaka A; Bita A; Lingani C; Fernandez K; Durupt A; Mwenda JM; Mihigo R; Djingarey MH; Ronveaux O; Preziosi MP
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S140-S147. PubMed ID: 31671448
[TBL] [Abstract][Full Text] [Related]
9. Product development partnerships hit their stride: lessons from developing a meningitis vaccine for Africa.
Bishai DM; Champion C; Steele ME; Thompson L
Health Aff (Millwood); 2011 Jun; 30(6):1058-64. PubMed ID: 21653957
[TBL] [Abstract][Full Text] [Related]
10. Serogroup A meningococcal conjugate vaccines in Africa.
Kristiansen PA; Jørgensen HJ; Caugant DA
Expert Rev Vaccines; 2015; 14(11):1441-58. PubMed ID: 26358167
[TBL] [Abstract][Full Text] [Related]
11. The Evolution of the Meningitis Vaccine Project.
Tiffay K; Jodar L; Kieny MP; Socquet M; LaForce FM
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S396-403. PubMed ID: 26553666
[TBL] [Abstract][Full Text] [Related]
12. Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®.
Trotter CL; Cibrelus L; Fernandez K; Lingani C; Ronveaux O; Stuart JM
Vaccine; 2015 Nov; 33(46):6212-7. PubMed ID: 26463444
[TBL] [Abstract][Full Text] [Related]
13. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
Okoko BJ; Idoko OT; Adegbola RA
Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
[TBL] [Abstract][Full Text] [Related]
14. The Meningitis Vaccine Project.
LaForce FM; Konde K; Viviani S; Préziosi MP
Vaccine; 2007 Sep; 25 Suppl 1():A97-100. PubMed ID: 17521780
[TBL] [Abstract][Full Text] [Related]
15. Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014.
Djingarey MH; Diomandé FV; Barry R; Kandolo D; Shirehwa F; Lingani C; Novak RT; Tevi-Benissan C; Perea W; Preziosi MP; LaForce FM
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S434-41. PubMed ID: 26553672
[TBL] [Abstract][Full Text] [Related]
16. Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM).
Frasch CE; Preziosi MP; LaForce FM
Hum Vaccin Immunother; 2012 Jun; 8(6):715-24. PubMed ID: 22495119
[TBL] [Abstract][Full Text] [Related]
17. Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
Fernandez K; Lingani C; Aderinola OM; Goumbi K; Bicaba B; Edea ZA; Glèlè C; Sarkodie B; Tamekloe A; Ngomba A; Djingarey M; Bwaka A; Perea W; Ronveaux O
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S225-S232. PubMed ID: 31671449
[TBL] [Abstract][Full Text] [Related]
18. Communication Challenges During the Development and Introduction of a New Meningococcal Vaccine in Africa.
Berlier M; Barry R; Shadid J; Sirica C; Brunier A; Hasan H; Bouma E
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S451-8. PubMed ID: 26553674
[TBL] [Abstract][Full Text] [Related]
19. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.
Mohammed I; Iliyasu G; Habib AG
Pathog Glob Health; 2017 Feb; 111(1):1-6. PubMed ID: 28081671
[TBL] [Abstract][Full Text] [Related]
20. Meningitis A conjugate vaccine comes on stream.
Ahmad K
Lancet Infect Dis; 2003 May; 3(5):263. PubMed ID: 12726961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
